179 related articles for article (PubMed ID: 35262977)
1. Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods.
López-Medrano F; Muñoz de la Espada M; Pérez-Jacoiste Asín MA; Fernández-Ruiz M; Herrero-Martínez JM; Alonso-Carrillo J; San Juan R; Rodríguez-Goncer I; Andrés A; González E; Manrique A; Justo I; Marcacuzco A; Loinaz C; Jiménez C; Lumbreras C; Aguado JM
Mycoses; 2022 May; 65(5):517-525. PubMed ID: 35262977
[TBL] [Abstract][Full Text] [Related]
2. Limitations of antifungal prophylaxis in preventing invasive
Carugati M; Arif S; Yarrington ME; King LY; Harris M; Evans K; Barbas AS; Sudan DL; Perfect JR; Miller RA; Alexander BD
Antimicrob Agents Chemother; 2024 Mar; 68(3):e0127923. PubMed ID: 38299818
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation.
Linder KA; Kauffman CA; Patel TS; Fitzgerald LJ; Richards BJ; Miceli MH
Transpl Infect Dis; 2021 Feb; 23(1):e13448. PubMed ID: 33448560
[TBL] [Abstract][Full Text] [Related]
5. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Candida infections with fluconazole in adult liver transplant recipients: Is TDM-guided dosing adaptation helpful?
Righi E; Carnelutti A; Baccarani U; Sartor A; Cojutti P; Bassetti M; Pea F
Transpl Infect Dis; 2019 Aug; 21(4):e13113. PubMed ID: 31106504
[TBL] [Abstract][Full Text] [Related]
7. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
Ziakas PD; Kourbeti IS; Mylonakis E
Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
[TBL] [Abstract][Full Text] [Related]
8. Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis.
Baker AW; Maziarz EK; Arnold CJ; Johnson MD; Workman AD; Reynolds JM; Perfect JR; Alexander BD
Clin Infect Dis; 2020 Jan; 70(1):30-39. PubMed ID: 30801642
[TBL] [Abstract][Full Text] [Related]
9. Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species.
Ou HT; Lee TY; Chen YC; Charbonneau C
BMC Infect Dis; 2017 Jul; 17(1):481. PubMed ID: 28693479
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation.
Schonfeld W; Wang Cheng J; Tong KB; Seifeldin R
Clin Ther; 2008 May; 30(5):964-73. PubMed ID: 18555943
[TBL] [Abstract][Full Text] [Related]
11. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
Cross SA; Scott LJ
Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009
[TBL] [Abstract][Full Text] [Related]
12. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
[TBL] [Abstract][Full Text] [Related]
13. A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients.
Kang WH; Song GW; Lee SG; Suh KS; Lee KW; Yi NJ; Joh JW; Kwon CHD; Kim JM; Choi DL; Kim JD; Kim MS
J Gastrointest Surg; 2020 Apr; 24(4):832-840. PubMed ID: 31066013
[TBL] [Abstract][Full Text] [Related]
14. [Results of the use of micafungin in newborns].
Çakır SÇ; Çelebi S; Özkan H; Köksal N; Dorum BA; Yeşil E; Hacımustafaoğlu M
Mikrobiyol Bul; 2019 Jan; 53(1):70-80. PubMed ID: 30683041
[TBL] [Abstract][Full Text] [Related]
15. [Micafungin in invasive candidiasis among oncohematological patients].
Jarque I; Angel Sanz M
Rev Iberoam Micol; 2009 Mar; 26(1):75-7. PubMed ID: 19463282
[TBL] [Abstract][Full Text] [Related]
16. Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.
van der Geest PJ; Hunfeld NG; Ladage SE; Groeneveld AB
BMC Infect Dis; 2016 Sep; 16():490. PubMed ID: 27634140
[TBL] [Abstract][Full Text] [Related]
17. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
18. Effect of coccidioidomycosis prophylaxis in selecting non-Candida albicans species amongst solid organ transplant recipients in Arizona.
Al-Obaidi MM; Marquez J; Afghan A; Zangeneh TT
Mycoses; 2023 Mar; 66(3):237-241. PubMed ID: 36401812
[TBL] [Abstract][Full Text] [Related]
19. The incidence of fungal infections in pancreas transplant recipients in the absence of systemic antifungal prophylaxis.
Shaikh SA; Zimmerman A; Nolan A; Cooper M; Abrams PL
Clin Transplant; 2019 Oct; 33(10):e13691. PubMed ID: 31400149
[TBL] [Abstract][Full Text] [Related]
20. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections.
Scott LJ
Drugs; 2012 Nov; 72(16):2141-65. PubMed ID: 23083111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
